| Cytogenetic analysis of Greek farmers using the micronucleus assay in peripheral lymphocytes and buccal cells S Pastor, S Gutiérrez, A Creus, N Xamena, S Piperakis, R Marcos Mutagenesis 16 (6), 539-545, 2001 | 499 | 2001 |
| RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer C Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, A Llop-Guevara, ... Annals of Oncology 29 (5), 1203-1210, 2018 | 405 | 2018 |
| A follow-up study on micronucleus frequency in Spanish agricultural workers exposed to pesticides S Pastor, L Lucero, S Gutiérrez, R Durban, C Gómez, T Parrón, A Creus, ... Mutagenesis 17 (1), 79-82, 2002 | 373 | 2002 |
| A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA F Gemignani, V Moreno, S Landi, N Moullan, A Chabrier, ... Oncogene 23 (10), 1954-1956, 2004 | 261 | 2004 |
| A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation M Castroviejo‐Bermejo, C Cruz, A Llop‐Guevara, S Gutiérrez‐Enríquez, ... EMBO molecular medicine 10 (12), 2018 | 259 | 2018 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 201 | 2017 |
| Micronuclei in peripheral blood lymphocytes and buccal epithelial cells of Polish farmers exposed to pesticides S Pastor, S Gutiérrez, A Creus, A Cebulska-Wasilewska, R Marcos Mutation Research/Genetic Toxicology and Environmental Mutagenesis 495 (1-2 …, 2001 | 185 | 2001 |
| Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification MT Parsons, E Tudini, H Li, E Hahnen, B Wappenschmidt, L Feliubadaló, ... Human mutation 40 (9), 1557-1578, 2019 | 144 | 2019 |
| Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients CN Andreassen, BS Rosenstein, SL Kerns, H Ostrer, D De Ruysscher, ... Radiotherapy and Oncology 121 (3), 431-439, 2016 | 135 | 2016 |
| Radiogenomics: radiobiology enters the era of big data and team science BS Rosenstein, CM West, SM Bentzen, J Alsner, CN Andreassen, D Azria, ... International journal of radiation oncology, biology, physics 89 (4), 709-713, 2014 | 126 | 2014 |
| Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium M Colombo, MJ Blok, P Whiley, M Santamarina, S Gutierrez-Enriquez, ... Human molecular genetics 23 (14), 3666-3680, 2014 | 113 | 2014 |
| Functional consequences of ATM sequence variants for chromosomal radiosensitivity S Gutiérrez‐Enríquez, M Fernet, T Dörk, M Bremer, A Lauge, ... Genes, Chromosomes and Cancer 40 (2), 109-119, 2004 | 94 | 2004 |
| Genomic Rearrangements at the BRCA1 Locus in Spanish Families with Breast/Ovarian Cancer M De La Hoya, S Gutierrez-Enriquez, E Velasco, A Osorio, AS de Abajo, ... Clinical chemistry 52 (8), 1480-1485, 2006 | 93 | 2006 |
| Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer: a study using the micronucleus test S Gutiérrez, E Carbonell, P Galofré, A Creus, R Marcos European journal of nuclear medicine 26, 1589-1596, 1999 | 92 | 1999 |
| REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer P Seibold, A Webb, ME Aguado-Barrera, D Azria, C Bourgier, M Brengues, ... Radiotherapy and Oncology 138, 59-67, 2019 | 88 | 2019 |
| Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing PJ Whiley, M De La Hoya, M Thomassen, A Becker, R Brandão, ... Clinical chemistry 60 (2), 341-352, 2014 | 86 | 2014 |
| Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity GC Barnett, RM Elliott, J Alsner, CN Andreassen, O Abdelhay, NG Burnet, ... Radiotherapy and Oncology 105 (3), 289-295, 2012 | 83 | 2012 |
| Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings S Bonache, I Esteban, A Moles-Fernández, A Tenés, L Duran-Lozano, ... Journal of cancer research and clinical oncology 144, 2495-2513, 2018 | 76 | 2018 |
| Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members M Thomassen, A Blanco, M Montagna, TVO Hansen, IS Pedersen, ... Breast cancer research and treatment 132, 1009-1023, 2012 | 76 | 2012 |
| Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples JD Fackenthal, T Yoshimatsu, B Zhang, GR de Garibay, M Colombo, ... Journal of medical genetics 53 (8), 548-558, 2016 | 69 | 2016 |
Ricard MarcosUniversitat Autonòma de BarcelonaEmail verificata su uab.es